Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Permanyer
2022-07-01
|
| סדרה: | Gaceta Mexicana de Oncología |
| נושאים: | |
| גישה מקוונת: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|